Daniel J. Kroon

1.0k total citations
18 papers, 795 citations indexed

About

Daniel J. Kroon is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Daniel J. Kroon has authored 18 papers receiving a total of 795 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Immunology. Recurrent topics in Daniel J. Kroon's work include Chemical Synthesis and Analysis (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Protein purification and stability (3 papers). Daniel J. Kroon is often cited by papers focused on Chemical Synthesis and Analysis (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Protein purification and stability (3 papers). Daniel J. Kroon collaborates with scholars based in United States. Daniel J. Kroon's co-authors include E. T. Kaiser, Daikichi Fukushima, Tapan Audhya, Gideon Goldstein, George A. Heavner, Alan J. Fischman, Ferenc J. Kézdy, Josh P. Kupferberg, R H Rubin and Howard F. Solomon and has published in prestigious journals such as Science, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Daniel J. Kroon

18 papers receiving 751 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel J. Kroon United States 16 460 287 136 118 108 18 795
Jeffrey A. Mattis United States 15 540 1.2× 634 2.2× 157 1.2× 261 2.2× 66 0.6× 25 1.2k
R. Schindler Switzerland 19 665 1.4× 96 0.3× 180 1.3× 117 1.0× 60 0.6× 61 1.1k
Albert Boosman United States 11 589 1.3× 73 0.3× 339 2.5× 271 2.3× 40 0.4× 13 1.1k
Katalin Uray Hungary 13 396 0.9× 135 0.5× 153 1.1× 64 0.5× 38 0.4× 41 620
Thomas Flad Germany 16 511 1.1× 108 0.4× 356 2.6× 221 1.9× 64 0.6× 25 1.0k
Hermann Beck Germany 11 766 1.7× 431 1.5× 246 1.8× 100 0.8× 31 0.3× 16 1.0k
William B. McCombs United States 10 585 1.3× 119 0.4× 129 0.9× 418 3.5× 83 0.8× 15 1.1k
I R Katz United States 12 295 0.6× 43 0.1× 142 1.0× 87 0.7× 76 0.7× 21 652
James M. Samanen United States 21 597 1.3× 157 0.5× 38 0.3× 110 0.9× 50 0.5× 34 1.1k
Oliver Demmer Germany 11 525 1.1× 176 0.6× 232 1.7× 410 3.5× 44 0.4× 14 987

Countries citing papers authored by Daniel J. Kroon

Since Specialization
Citations

This map shows the geographic impact of Daniel J. Kroon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel J. Kroon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel J. Kroon more than expected).

Fields of papers citing papers by Daniel J. Kroon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel J. Kroon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel J. Kroon. The network helps show where Daniel J. Kroon may publish in the future.

Co-authorship network of co-authors of Daniel J. Kroon

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel J. Kroon. A scholar is included among the top collaborators of Daniel J. Kroon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel J. Kroon. Daniel J. Kroon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Johnson, Dana L., Francis X. Farrell, Francis P. Barbone, et al.. (1997). Amino-terminal dimerization of an erythropoietin mimetic peptide results in increased erythropoietic activity. Chemistry & Biology. 4(12). 939–950. 46 indexed citations
2.
Johnson, Dana L., Steven A. Middleton, Frank J. McMahon, et al.. (1996). Refolding, Purification, and Characterization of Human Erythropoietin Binding Protein Produced inEscherichia coli. Protein Expression and Purification. 7(1). 104–113. 27 indexed citations
3.
Derian, Claudia K., Howard F. Solomon, John Higgins, et al.. (1996). Selective Inhibition ofN-Formylpeptide-Induced Neutrophil Activation by Carbamate-Modified Peptide Analogues. Biochemistry. 35(4). 1265–1269. 58 indexed citations
4.
Kroon, Daniel J., et al.. (1995). Rapid profiling of carbohydrate glycoforms in monoclonal antibodies using MALDI/TOF mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 13(8). 1049–1054. 17 indexed citations
5.
Rauh, Daniel, Hilla Solomon, Ronald G. Tompkins, et al.. (1993). In vivo bioactivity and biodistribution of chemotactic peptide analogs in nonhuman primates.. PubMed. 34(12). 2130–4. 51 indexed citations
6.
Babich, John W., Howard F. Solomon, Marilyn C. Pike, et al.. (1993). Technetium-99m-labeled hydrazino nicotinamide derivatized chemotactic peptide analogs for imaging focal sites of bacterial infection.. PubMed. 34(11). 1964–74. 81 indexed citations
7.
Kroon, Daniel J., et al.. (1992). Identification of Sites of Degradation in a Therapeutic Monoclonal Antibody by Peptide Mapping. Pharmaceutical Research. 9(11). 1386–1393. 92 indexed citations
8.
Fischman, Alan J., M C Pike, Daniel J. Kroon, et al.. (1991). Imaging focal sites of bacterial infection in rats with indium-111-labeled chemotactic peptide analogs.. PubMed. 32(3). 483–91. 74 indexed citations
9.
Lenert, Petar, Daniel J. Kroon, Hans L. Spiegelberg, Edward S. Golub, & Maurizio Zanetti. (1990). Human CD4 Binds Immunoglobulins. Science. 248(4963). 1639–1643. 46 indexed citations
10.
Audhya, Tapan, Daniel J. Kroon, George A. Heavner, George I. Viamontes, & Gideon Goldstein. (1986). Tripeptide Structure of Bursin, a Selective B-Cell-Differentiating Hormone of the Bursa of Fabricius. Science. 231(4741). 997–999. 64 indexed citations
11.
Heavner, George A., Daniel J. Kroon, Tapan Audhya, & Gideon Goldstein. (1986). Biologically active analogs of thymopentin with enhanced enzymatic stability. Peptides. 7(6). 1015–1019. 24 indexed citations
12.
Heavner, George A., Tapan Audhya, Daniel J. Kroon, & Gideon Goldstein. (1985). Structural requirements for the biological activity of thymopentin analogs. Archives of Biochemistry and Biophysics. 242(1). 248–255. 15 indexed citations
13.
Audhya, Tapan, George A. Heavner, Daniel J. Kroon, & Gideon Goldstein. (1984). Cooperativity of thymopoietin 32–36 (the active site) and thymopoietin 38–45 in receptor binding. Regulatory Peptides. 9(3). 155–164. 11 indexed citations
14.
Fukushima, Daikichi, Shinji Yokoyama, Daniel J. Kroon, Ferenc J. Kézdy, & E. T. Kaiser. (1980). Chain length-function correlation of amphiphilic peptides. Synthesis and surface properties of a tetratetracontapeptide segment of apolipoprotein A-I.. Journal of Biological Chemistry. 255(22). 10651–10657. 67 indexed citations
15.
Fukushima, Daikichi, E. T. Kaiser, Ferenc J. Kézdy, et al.. (1980). RATIONAL DESIGN OF SYNTHETIC MODELS FOR LIPOPROTEINS *. Annals of the New York Academy of Sciences. 348(1). 365–377. 11 indexed citations
16.
Fukushima, Daikichi, et al.. (1979). A synthetic amphiphilic helical docosapeptide with the surface properties of plasma apolipoprotein A-I. Journal of the American Chemical Society. 101(13). 3703–3704. 65 indexed citations
17.
Kroon, Daniel J. & E. T. Kaiser. (1978). Studies on the solid-phase synthesis of peptide fragments of apolipoproteins A-I and A-II. The Journal of Organic Chemistry. 43(11). 2107–2113. 18 indexed citations
18.
Kroon, Daniel J., Josh P. Kupferberg, E. T. Kaiser, & Ferenc J. Kézdy. (1978). Mechanism of lipid-protein interaction in lipoproteins. A synthetic peptide-lecithin vesicle model. Journal of the American Chemical Society. 100(18). 5975–5977. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey A. Mattis Breakdown of academic impact, for papers by R. Schindler Breakdown of academic impact, for papers by Albert Boosman Breakdown of academic impact, for papers by Katalin Uray Breakdown of academic impact, for papers by Thomas Flad Breakdown of academic impact, for papers by Hermann Beck Breakdown of academic impact, for papers by William B. McCombs Breakdown of academic impact, for papers by I R Katz Breakdown of academic impact, for papers by James M. Samanen Breakdown of academic impact, for papers by Oliver Demmer
Rankless by CCL
2026